161 related articles for article (PubMed ID: 29351208)
1. Preservation Method and Phosphate Buffered Saline Washing Affect the Acute Myeloid Leukemia Proteome.
Wangen R; Aasebø E; Trentani A; Døskeland SO; Bruserud Ø; Selheim F; Hernandez-Valladares M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351208
[TBL] [Abstract][Full Text] [Related]
2. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.
Aasebø E; Mjaavatten O; Vaudel M; Farag Y; Selheim F; Berven F; Bruserud Ø; Hernandez-Valladares M
J Proteomics; 2016 Aug; 145():214-225. PubMed ID: 27107777
[TBL] [Abstract][Full Text] [Related]
3. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.
Aasebø E; Vaudel M; Mjaavatten O; Gausdal G; Van der Burgh A; Gjertsen BT; Døskeland SO; Bruserud O; Berven FS; Selheim F
Proteomics; 2014 Sep; 14(17-18):1971-6. PubMed ID: 25044641
[TBL] [Abstract][Full Text] [Related]
4. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
Hernandez-Valladares M; Bruserud Ø; Selheim F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
[TBL] [Abstract][Full Text] [Related]
5. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G
Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteome analysis of acute myeloid leukemia with and without maturation.
Luczak M; Kaźmierczak M; Handschuh L; Lewandowski K; Komarnicki M; Figlerowicz M
J Proteomics; 2012 Oct; 75(18):5734-48. PubMed ID: 22850270
[TBL] [Abstract][Full Text] [Related]
7. A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.
Hu CW; Qiu Y; Ligeralde A; Raybon AY; Yoo SY; Coombes KR; Qutub AA; Kornblau SM
Nat Biomed Eng; 2019 Nov; 3(11):889-901. PubMed ID: 30988472
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of proteomics in acute myeloid leukemia.
Czibere A; Grall F; Aivado M
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1663-75. PubMed ID: 17134369
[TBL] [Abstract][Full Text] [Related]
9. Plasma proteome coverage is increased by unique peptide recovery from sodium deoxycholate precipitate.
Serra A; Zhu H; Gallart-Palau X; Park JE; Ho HH; Tam JP; Sze SK
Anal Bioanal Chem; 2016 Mar; 408(7):1963-73. PubMed ID: 26804737
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspective.
van Dijk AD; de Bont ESJM; Kornblau SM
Expert Rev Proteomics; 2020 Jan; 17(1):1-10. PubMed ID: 31945303
[No Abstract] [Full Text] [Related]
11. [Comparison of proteomics between acute myeloid leukemia and acute lymphoid leukemia].
Xiao P; Zeng YY; Nie YF; Lin W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1353-6. PubMed ID: 22169282
[TBL] [Abstract][Full Text] [Related]
12. Angiocidin induces differentiation of acute myeloid leukemia cells.
Tuszynski GP; Rothman VL
Exp Mol Pathol; 2013 Dec; 95(3):249-54. PubMed ID: 24036285
[TBL] [Abstract][Full Text] [Related]
13. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
[TBL] [Abstract][Full Text] [Related]
14. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
15. Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia.
Alanazi B; Munje CR; Rastogi N; Williamson AJK; Taylor S; Hole PS; Hodges M; Doyle M; Baker S; Gilkes AF; Knapper S; Pierce A; Whetton AD; Darley RL; Tonks A
Leukemia; 2020 Feb; 34(2):427-440. PubMed ID: 31611628
[TBL] [Abstract][Full Text] [Related]
16. Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis.
Teng PN; Rungruang BJ; Hood BL; Sun M; Flint MS; Bateman NW; Dhir R; Bhargava R; Richard SD; Edwards RP; Conrads TP
J Proteome Res; 2010 Aug; 9(8):4161-9. PubMed ID: 20518575
[TBL] [Abstract][Full Text] [Related]
17. Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia.
Hernandez-Valladares M; Aasebø E; Selheim F; Berven FS; Bruserud Ø
Proteomes; 2016 Aug; 4(3):. PubMed ID: 28248234
[TBL] [Abstract][Full Text] [Related]
18. Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.
Aasebø E; Forthun RB; Berven F; Selheim F; Hernandez-Valladares M
Curr Pharm Biotechnol; 2016; 17(1):52-70. PubMed ID: 26306748
[TBL] [Abstract][Full Text] [Related]
19. Screening for methylation-silenced genes in acute myeloid leukemia HL-60 cell line by a quantitative proteomic approach.
Tang C; Tan T; Xiao Y; Ruan L; Li C; Peng F; Li M; Zhang P; Yi H; Xiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):641-8. PubMed ID: 20693703
[TBL] [Abstract][Full Text] [Related]
20. Profiling of the secretome of human cancer cells: preparation of supernatant for proteomic analysis.
Rogers LJ; Suchowerska N; Khan A; Polaskova V; McKenzie DR
Electrophoresis; 2014 Sep; 35(18):2626-33. PubMed ID: 24890906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]